Our re rating maybe coming:
https://-----head.com.au/health/fundie-merchant-group-picks-four-biotech-stocks-that-could-rip-as-sector-hits-rude-health-again/?utm_medium=email&utm_campaign=Lunchtime%20-02-19-2024&utm_content=httpsstockheadcomauhealthfundiemerchantgrouppicksfourbiotechstocksthatcouldripassectorhitsrudehealthagain&utm_medium=email&utm_campaign=Morning%20email%20Tuesday%20February%2020&utm_content=Morning%20email%20Tuesday%20February%2020+CID_23378f0f9a14c792585ffce5ff9a2003&utm_source=Campaign%20Monitor&utm_term=Fundie%20Merchant%20Group%20picks%20four%20biotech%20stocks%20that%20could%20rip%20as%20sector%20hits%20rude%20health%20again
Replace ----= with Stock
Significant Re Rating $80 to $800m, page-8
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.001(1.69%) |
Mkt cap ! $60.00M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.0¢ | 5.8¢ | $16.67K | 280.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 344807 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 128477 | 2 |
View Market Depth
| Last trade - 15.53pm 03/10/2024 (20 minute delay) ? |
| NTI (ASX) Chart |